NCT02023970View on ClinicalTrials.gov

TRANSLINK: Defining the Role of Xeno-directed and Immune Events (SVD) in Patients Receiving Animal-derived Bioprosthetic Heart Valves

NACompletedINTERVENTIONAL
Enrollment

1,668

Participants

Timeline

Start Date

January 6, 2014

Primary Completion Date

January 10, 2018

Study Completion Date

January 10, 2018

Conditions
Patients Receiving Animal-derived Bioprosthetic Heart Valves
Interventions
DEVICE

Patients receiving animal-derived bioprosthetic heart valves.

OTHER

Echocardiography (1)

OTHER

Echocardiography (2)

OTHER

Echocardiography (3)

BIOLOGICAL

Blood sample (1)

BIOLOGICAL

Blood sample (2)

BIOLOGICAL

Blood sample (3)

Trial Locations (5)

Unknown

University of Manitoba, Winnipeg

Nantes University Hospital, Nantes

University of Padova Medical School, Italy, Padua

University Hospital of Bellvitge, Barcelona, Spain, Barcelona

University Hospital Vall d'Hebron, Barcelona, Spain, Barcelona

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT02023970 - TRANSLINK: Defining the Role of Xeno-directed and Immune Events (SVD) in Patients Receiving Animal-derived Bioprosthetic Heart Valves | Biotech Hunter | Biotech Hunter